The ESPRIT Study: Estrogen Suppression and Perfusion Reserve With Aromatase-Inhibitor Treatment in Premenopausal Women With Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Regadenoson (Primary) ; Adenosine
- Indications Heart disorders
- Focus Therapeutic Use
- Acronyms ESPRIT Study
- 27 Jun 2018 Status changed from not yet recruiting to recruiting.
- 26 Apr 2018 Planned initiation date changed from 1 May 2018 to 1 Jun 2018.
- 26 Apr 2018 New trial record